Welcome to Galmedpharma.investorroom.com

galmedpharma.investorroom.com

Description: Galmedpharma Investorroom. Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of Aramchol,...

Google PR 0

Trustworthiness Unknown
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Unknown

Investors Center

Galmedpharma.investorroom.com: get to the top rated Galmedpharma Investorroom pages and content popular with India-based Galmedpharma.investorroom.com users or check the following digest to find out more. Galmedpharma.investorroom.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Galmedpharma.investorroom.com team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Galmedpharma.investorroom.com is hosted with CloudFlare, Inc. in United States. Galmedpharma Investorroom traffic is not yet estimated by Alexa.

Visit galmedpharma.investorroom.com

Domain info

Location:	United States
Registrant:	Not Disclosed Not Disclosed (Not Disclosed)
Hosted by:	CloudFlare, Inc.
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	104.17.202.159, 104.17.203.159, 104.17.204.159, 104.17.205.159, 104.17.206.159

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Galmedpharma.investorroom.com popular pages to visit

Investors Center Earnings Events data provided by Wall Street Horizon. ' }, shape : 'rectpin', width : 11, y: -45 }; var type_options = { dividends: { name: 'Dividend', ti...

Galmed Pharmaceuticals and Weizmann Institute of Science to enter a research collaboration agreement to assess Aramchol™ effects Sign-up to receive news as it is released.

Aramchol™ Demonstrates Significant Anti-Fibrotic Effect in a Pre-clinical Model of Fatty Liver Disease - Mar 30, 2016 Aramchol™ Demonstrates Significant Anti-Fibrotic Effect in a Pre-clinical Model of Fatty Liver Disease Mar 30, 2016 TEL AVIV, Israel, March 30, 2016 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq...